Isracann Biosciences Inc. Stock

Equities

IPOT

CA46501D1087

Pharmaceuticals

Delayed Canadian Securities Exchange 10:41:13 2023-04-05 am EDT 5-day change 1st Jan Change
0.015 CAD -.--% Intraday chart for Isracann Biosciences Inc. -.--% -.--%
Sales 2021 - Sales 2022 - Capitalization 11.08M 15.14M
Net income 2021 -25M -34.16M Net income 2022 -4M -5.47M EV / Sales 2021 -
Net cash position 2021 1.96M 2.68M Net cash position 2022 214K 292K EV / Sales 2022 -
P/E ratio 2021
-1.21 x
P/E ratio 2022
-2.2 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 99.83%
More Fundamentals * Assessed data
Dynamic Chart
3 years
0.00
Extreme 0
0.30
5 years
0.00
Extreme 0
0.68
10 years
0.00
Extreme 0
0.68
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-01-19
Director of Finance/CFO 42 17-11-14
Chief Tech/Sci/R&D Officer 44 20-06-03
Members of the board TitleAgeSince
Director/Board Member 52 19-07-04
Director/Board Member 34 17-12-18
Director of Finance/CFO 42 17-11-14
More insiders
Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.
More about the company